iCardio.ai Wins $1M Roddenberry Foundation Grand Prize towards "AI for Good"

The 2024 Roddenberry Prize spotlighted innovative science and technology ventures leveraging Artificial Intelligence (AI) to drive transformative, lasting change. This year’s Grand Prize Winner, iCardio.ai, was recognized for its pioneering use of AI to revolutionize heart health diagnostics. iCardio.ai’s AI-powered platform automates the interpretation of cardiac ultrasounds, providing real-time analysis of heart health and detecting structural heart disease with unprecedented accuracy. Alongside iCardio.ai, finalist Noetik was awarded a $250,000 grant for its AI-driven cancer immunotherapy platform, which employs advanced machine learning to create personalized cancer treatments, potentially improving immunotherapy on a global scale.

iCardio.ai's awardee as the recipient of the 2024 Roddenberry Prize from The Roddenberry Foundation pays tribute to Gene Roddenberry, the visionary creator of Star Trek, whose forward-thinking ideas and visions of futuristic technology align with our ambitions at iCardio.ai. We are excited to use this grant funding to democratize access to quality care in underserved populations in the USA and worldwide.

About the Roddenberry Prize
The Roddenberry Prize, the flagship initiative of The Roddenberry Foundation, is awarded bi-annually to breakthrough science and technology ventures creating positive, lasting change. With this year's focus on AI for good, the Prize supports organizations that are using artificial intelligence and related technologies to tackle some of the world's most urgent challenges, from healthcare to environmental sustainability. Through this $1 million grant, the Roddenberry Foundation aims to catalyze breakthrough solutions that make a meaningful impact on society. For more information please contact us at press@roddenberryfoundation.org